Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-&#954;B and STATs Regulated Genes.

Wanas, Hanaa; Elbadawy, Hossein M; Almikhlafi, Mohannad A; Hamoud, Amany E; Ali, Eid N; Galal, Amr M

Combination of Niclosamide and Pirfenidone Alleviates Pulmonary Fibrosis by Inhibiting Oxidative Stress and MAPK/Nf-κB and STATs Regulated Genes.

Wanas, Hanaa; Elbadawy, Hossein M; Almikhlafi, Mohannad A; Hamoud, Amany E; Ali, Eid N; Galal, Amr M.

Afiliação

Wanas H; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi Arabia.
Elbadawy HM; Department of Medical Pharmacology, Faculty of Medicine, Cairo University, Cairo 11956, Egypt.
Almikhlafi MA; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi Arabia.
Hamoud AE; Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Madinah 41477, Saudi Arabia.
Ali EN; Department of Anatomy and Embryology, Faculty of Medicine, Cairo University, Cairo 11956, Egypt.
Galal AM; Department of Anatomy and Embryology, Faculty of Medicine, Cairo University, Cairo 11956, Egypt.

Pharmaceuticals (Basel) ; 16(5)2023 May 04.

Article em En | MEDLINE | ID: mdl-37242480

Palavras-chave

bleomycin; lung fibrosis; niclosamide; pirfenidone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google